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On November 4, 2010, the Republic of the Congo 
declared a poliomyelitis outbreak. A cross-sectional survey 
in Pointe-Noire showed poor sanitary conditions and low 
vaccination coverage (55.5%), particularly among young 
adults. Supplementary vaccination should focus on older 
age groups in countries with evidence of immunity gaps.
O
n November 4, 2010, the Ministry of Health of 
the Republic of the Congo ofﬁ   cially declared a 
poliomyelitis outbreak centered in Pointe-Noire following 
the laboratory identiﬁ  cation of poliovirus type 1 in a patient 
with acute ﬂ  accid paralysis (AFP) (1,2). A provisional total 
of 554 AFP case-patients that included a high proportion 
(68%) of male patients was identiﬁ   ed nationally, with 
paralysis onset from September 20, 2010, through February 
27, 2011 (3). During this same period, 451 cases (81.4%), 
which included 184 deaths, were reported in Pointe-Noire. 
Most cases were found in the young adult population 
(57.4% in patients 15–24 years of age), which had a higher 
case-fatality ratio (CFR) of 40.8% compared with the 
general population of the country (3).
In most developing countries, prevention and control 
of poliomyelitis relies on oral polio vaccine (OPV). 
Routine vaccination focuses on infants <11 months of 
age with trivalent OPV, and supplementary immunization 
activities (SIAs) provide additional opportunities for 
vaccination for children <5 years of age (4,5). In response 
to the epidemic, the Ministry of Health, in collaboration 
with the World Health Organization, launched 4 rounds 
of national SIAs that used monovalent type 1 and bivalent 
types 1 and 3 OPV during November 12–16, 2010, 
December 3–7, 2010, January 11–15, 2011, and February 
22–26, 2011 (3). To assess risk factors for infection and 
estimate vaccination coverage, Epicentre and Médecins 
Sans Frontières implemented a cross-sectional survey in 1 
affected neighborhood of Pointe-Noire.
The Study
This survey was a single-community rapid assessment 
of epidemiologic conditions potentially contributing to the 
outbreak, including vaccination coverage. The survey was 
done in Mbota, a neighborhood composed of 4 sectors, 
comprising 9.5% of the city population. This neighborhood 
was selected from Loandjili district (Figure 1) on the 
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Figure 1. Pointe-Noire, Republic of the Congo, representing the 
4 districts, Lumuba, MvouMvou, Tie-Tie, and Loandjili. The gray 
scale represents the cumulative acute ﬂ  accid paralysis (AFP) rate 
per 100,000 inhabitants September 2010–February 2011. Black 
area represents the 4 sectors of Mbota where the cross-sectional 
survey took place. The last census provided by local health 
authorities occurred in 2007, with a growth rate applied to estimate 
the 2010 ofﬁ   cial population size in Pointe-Noire, aggregated by 
gender and age. We used a 2005 population survey to disaggregate 
population ﬁ  gures by gender and 5-year age groups and calculate 
speciﬁ  c acute ﬂ  accid paralysis rate. DRC, Democratic Republic of 
the Congo.Poliomyelitis Outbreak, Pointe-Noire, 2010–2011
basis of local expert consultation to ensure socioeconomic 
diversity and representativeness. To estimate vaccination 
coverage of 80% among children with 5% precision at a 
95% conﬁ  dence level, we aimed to sample at least 246 
households. We assumed each household had on average 
1 child <5 years of age. We also assumed 5 persons per 
household on average, which corresponds to ≈1,230 
persons overall. Households were selected in each sector 
of the neighborhood. From a starting point on the border 
of the sector, interviews focused on every ﬁ  fth household, 
following a predeﬁ  ned direction toward the center of the 
sector, subsequently covering the entire neighborhood. 
Data were collected through face-to-face interviews 
December 9–10, 2010, by using a structured questionnaire. 
The questions included household demographics, water 
supply, and sanitary conditions. In addition, information 
for each person in the household was collected about 
vaccination history (routine and SIAs), any previous 
illness, and access to health care during the past 3 months. 
Vaccination coverage was estimated on the basis of reported 
personal history or documentary evidence of vaccination: a 
ﬁ  ngernail marked with ink indicating vaccination during 
SIAs or a vaccination card indicating routine vaccination.
Data were eventually collected from 1,849 persons in 
317 households of Mbota with all ages and both genders 
represented. Following the 2 ﬁ  rst rounds of SIAs, most 
surveyed persons (1,812 [98%], 95% conﬁ  dence interval 
[CI] 97.3%–98.6%) reported having been vaccinated with 
monovalent OPV and 1,769 (95.7%, 95% CI 94.7%–
96.6%) received 2 doses in November and December 
2010. Among vaccinated persons, 627 (33.9%, 95% 
CI 31.7%–36.1%) had ﬁ  ngernails marked with ink; the 
rest were absent during the interview or ink had already 
worn off. There were no signiﬁ  cant differences in SIA 
vaccine coverage by gender or age. Routine vaccination 
coverage was estimated as 55.5% (95% CI 53.3%–57.8%) 
among the surveyed persons (Table 1). Among reported 
vaccinated persons, 21.3% (95% CI 18.8%–23.8%) 
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Table 1. Persons vaccinated against poliomyelitis (routine vaccination), by age and gender, Mbota, Pointe-Noire, Republic of the
Congo, December 2010 
Age, y, and 
gender 
No. (%) persons*  Total no. 
persons Vaccinated, card  Vaccinated, recall  Total vaccinated  Nonvaccinated Unknown 
<5
  M  43 (35.5)  67 (55.4)  110 (90.9)  5 (4.1)  6 (5)  121
  F  54 (36.2)  72 (48.3)  126 (84.5)  9 (6)  14 (9.4)  149
  Total  97 (35.9)  139 (51.5)  236 (87.4)  14 (5.2)  20 (7.4)  270
5–9
  M  26 (25.5)  53 (52)  79 (77.5)  10 (9.8)  13 (12.8)  102
  F  23 (20.9)  66 (60)  89 (80.9)  7 (6.4)  14 (12.7)  110
  Total  49 (23.1)  119 (56.1)  168 (79.2)  17 (8)  27 (12.7)  212
10–14 
  M  7(7.2)  62 (63.9)  69 (71.1)  9 (9.3)  19 (19.6)  97
  F  16 (16)  51 (51)  67 (67)  7 (7)  26 (26)  100
  Total  23 (11.7)  113 (57.4)  136 (69.1)  16 (8.1)  45 (22.8)  197
15–19 
  M  4 (4.4)  39 (42.4)  43 (46.8)  9 (9.8)  40 (43.5)  92
  F  8 (7.3)  49 (45)  57 (52.3)  12 (11)  40 (36.7)  109
  Total  12 (6)  88 (43.8)  100 (49.8)  21 (10.4)  80 (39.8)  201
20–24 
  M  2 (3)  25 (37.3)  27 (40.3)  7 (10.5)  33 (49.3)  67
  F  4 (3.2)  61 (48)  65 (51.2)  14 (11)  48 (37.8)  127
  Total  6 (3.1)  86 (44.3)  92 (47.4)  21 (10.8)  81 (41.8)  194
25–29 
  M  2 (2.3)  37 (43)  39 (45.3)  12 (14)  35 (40.7)  86
  F  11 (10.4)  50 (47.2)  61 (57.6)  15 (14.2)  30 (28.3)  106
  Total  13 (6.6)  87 (45.3)  100 (51.9)  27 (14.1)  65 (33.9)  192
>29
  M  4 (1.5)  80  (29.2)  84 (30.7)  33 (12)  157 (57.3)  274
  F  11 (4.2)  84 (32.3)  95 (36.5)  30 (11.5)  135 (51.9)  260
  Total  15 (2.8)  164 (30.7)  179 (33.5)  63 (11.8)  292 (54.7)  534
Totals 
  M  88 (10.5)  363 (43.3)  451 (53.8)  85 (10.1)  303 (36.1)  839
  F  127 (13.2)  433 (45.1)  560 (58.3)  94 (9.8)  307 (32)  961
  Total  215 (11.9)  796 (44.2)  1,011 (56.1)  179 (10)  610 (33.9)  1,800 
*Card, vaccination documented by card; recall, person remembers received vaccination; total, card + recall. showed their vaccination card, and among those, 78.7% 
(95% CI 73.1%–84.4%) were vaccinated >3 times. Routine 
vaccination coverage did not vary signiﬁ  cantly by gender 
but decreased with age (p <0.0001). For persons younger 
than 5 years, it was 87.5% (95% CI 83.6%–91.4%) and 
<52% for anyone >15 years of age.  In the most affected 
age groups, 15–19 and 20–24 years, vaccination coverage 
was estimated to be respectively 49.3% (95% CI 42.4%–
56.1%) and 46.2% (95% CI 39.3%–53.1%)  (Figure 2). By 
comparison, administrative vaccination coverage varied 
since 1986 between a reported 21% in 1997 and 112% in 
2009 (Table 2).
The number of persons per bedroom, an indicator 
of crowding, ranged between 1 and 9, and there were >4 
persons per bedroom for 12.1% (95% CI 8.4%–15.7%) of 
all households with no statistical differences among sectors. 
Tap water either from a neighbor’s house (41.9%, 95% CI 
35.9%–47.8%) or within the house (30.7%, 95% CI 25.2%–
36.3%) was the primary potable water source recorded. 
Wells were also common (23.3%, 95% CI 18.3%–28.4%). 
When the primary source of potable water was unavailable, 
wells were the most frequently mentioned alternative 
source (37.8%, 95% CI 32.0%–43.6%). Most households 
reported use of a latrine shared with neighbors (57.4%, 
95% CI 51.8%–63.1%) or within their house (31.4%, 95% 
CI 26.1%–36.7%). Few surveyed persons (16.1%, 95% CI 
14.4%–17.7%) reported illness during the recall period, but 
if sick, 73.3% (95% CI 67.4%–79.2%) they sought health 
care, which suggests little underreporting of AFP cases.
Conclusions
The cross-sectional survey conﬁ  rmed administrative 
estimates of low routine vaccination decreasing with age. 
Speciﬁ  cally, in the surveyed young adult population (15–29 
years of age) it varied between a reported 46.2% and 52.6%.  
According to administrative data, the reported vaccination 
coverage varies between 41.7% and 79% in young adults 
between 15 and 24 years of age. Civil conﬂ  icts spanning 
the 1990s have potentially undermined vaccination efforts, 
especially affecting those currently 10–20 years of age. A 
further method of protection for a person is past exposure to 
wildtype strains. To our knowledge, no polio transmission 
had been reported in Pointe-Noire since the last outbreak 
in the city in 1969 (6). Low vaccination coverage and no 
previous exposure to wild virus likely led to an accumulation 
of susceptible persons. Once introduced, the disease spread 
quickly through this highly susceptible, undervaccinated, 
and underexposed young adult population, with disease 
spread facilitated by frequent ﬂ  ooding and poor to medium 
household sanitation conditions, i.e., crowding sleeping 
areas, shared latrines between households, and common 
sources for water consumption.
Poliovirus infections lead to clinical disease more 
frequently in older age groups, (7), which partially explains 
the observed shift of AFP cases toward young adult 
populations. Moreover, children were better protected with 
higher vaccination coverage. Death is more frequent when 
infection occurs in older age groups (8,9), which explains 
part of the high observed CFR. Clinical manifestations of 
poliovirus infections are more common in boys and men 
than in girls and women (10), as observed, and even though 
males and females share similar vaccination coverage, 
women in the young adult age groups may have additionally 
beneﬁ  tted from exposure to excreted OPV while caring for 
the young (11).
As seen in the Republic of the Congo, or previously 
in Namibia (12), Cape-Verde (13), any country with no 
recent wild-type polio transmission and a similarly low 
level of vaccination coverage may face similar outbreaks 
characterized by a large proportion of cases in older age 
groups and a high CFR (14). Avoiding outbreaks will 
rely on ensuring vaccination of the at-risk population. 
Routine vaccination activities should be reinforced by SIAs 
punctually focusing on older age groups (especially among 
persons 15–35 years of age) when evidence of immunity 
gaps are documented by serologic surveys or low historical 
vaccination coverage data. Lessons from the epidemic 
should beneﬁ  t health authorities in better prevention and 
response to further outbreaks on the road to eradication.
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cohorts. Poliomyelitis Outbreak, Pointe-Noire, 2010–2011
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Table 2. Cumulative age-specific AFP rate and vaccination coverage from administrative data and a cross-sectional survey conducted 
in December 2010, by age group, Mbota, Pointe-Noire, Republic of the Congo*  
Age group, y 
AFP rate/100,000 
persons (95% CI) 
Survey vaccination coverage, 
% (95% CI) 
Administrative vaccination 
coverage,  % 
5-y average administrative 
vaccination coverage, % 
>29 23.1 (16.9–29.3)  33.3  (29.4–37.3)  † †
25–29  80.5  (59.2–101.8)  52.6 (45.5–59.6)  † †
20–24  151.1 (124.3–177.9)  46.2 (39.3–53.2)  41.7–79.0  67.0
15–19  136.5 (112.4–160.6)  49.3 (42.4–56.2)  47–77†  60.5† 
10–14  31.9 (20.7–43.2)  69.0 (62.6–75.5)  21–75†  36.7† 
5–9 16.3  (8.1–24.6)  79.3 (73.7–84.7)  38–67  53.1
0–4 44.5 (32.2–56.8)  87.5 (83.6–91.4)  81–112  93.9
*AFP, acute flaccid paralysis; CI, confidence interval. 
†Administrative vaccination coverage provided by health authorities at the country level 1986–2000, at the regional level 2001–2006, and at the city level 
2007–2009. Vaccination coverage was partially incomplete for 1992–2000 because of civil conflict. Thus, values for 1994, 1998, and 2000 consisted of 
interpolated values from years for which data are available.  
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